A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis

Exclusion Criteria

• •Failing renal allograft in place
• •Acute or chronic bleeding within 8 weeks prior to screening
• •Transfusion of red blood cells within 8 weeks prior to screening
• •Poorly controlled hypertension, defined as hypertension that needs hospitalization to obtain control
• •History of seizures, hemoglobinopathies and/or severe liver disease
• •Active malignant disease, except for non-melanoma skin cancer
• •Immunosuppressive therapy in the 12 weeks prior to screening
• •Treatment with any other investigational agent or participation in a clinical trial within 28 days prior to enrolment
• •Known hypersensitivity to Mircera (methoxy polyethylene glycol-epoetin beta) or any of its excipients
• •Pregnant or lactating women